SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently driving intense community discussion following reports of a partnership with Shift4 Payments, which has sparked speculation about broader enterprise software adoption. While bulls emphasize the company's expanding role in AI-driven data analytics and government contracts, bears remain focused on valuation concerns and the stock's recent choppy price action within a wider consolidation phase.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is currently trending as investors brace for the highly anticipated 80th event trigger in the REGAL Phase 3 trial, which will unblind the survival data and potentially catalyze a major acquisition. The community is intensely debating the stock's valuation, fueled by speculation regarding a multi-billion dollar buyout from big pharma players and significant upward pressure from elevated short borrow fees.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is experiencing significant upward momentum as investors speculate on upcoming FDA peptide reviews and growth from new product integrations. The stock is currently a major focus for retail and institutional traders, with the community actively debating potential short-squeeze mechanics and the company's ability to maintain its recent price breakout.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is gaining traction as traders debate its potential for a rebound, with the community split between those accumulating in anticipation of ecosystem expansion and others dismissing the project as a speculative gamble. This heightened interest is largely driven by persistent discussions around the token's role within Japan's blockchain infrastructure and its ability to weather broader market volatility.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is capturing significant market attention as it prepares for its Nasdaq-100 inclusion, with investors closely watching its massive multi-billion dollar contract backlog and recent AI training benchmark records. While the community remains divided between bullish sentiment regarding its infrastructure scale and bearish concerns over debt levels and insider selling, the stock continues to be a focal point of intense debate regarding the long-term sustainability of the AI cloud computing business model.

FreeCast, Inc. operates an online video streaming platform. Its cloud entertainment platform comprises the largest aggregated library of free and pay-per-view video-on-demand, streaming channels, live events, radio stations, music videos and online games. The company was founded by William A. Mobley, Jr. on June 21, 2011 and is headquartered in Orlando, FL.

Freecast Inc - Ordinary Shares - Class A

Freecast Inc

Freecast Inc. is experiencing extreme volatility and intense retail interest driven by a strategic reseller agreement with Starlink Business, fueling a massive short squeeze momentum. While retail bulls are aggressively targeting a continued rally and celebrating significant gains, community discourse remains sharply polarized between those betting on further upside potential and skeptics warning of imminent dilution risks and weak fundamentals.

BTQ Technologies Corp. engages in the business of post-quantum encryption. Its products include: QCIM, QSSN, OSS, QPoW, QRiNG. The company was founded by Nicolas Roussy Newton on Novemeber 23, 1983 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies is trending as investors debate the impact of the company's new C$150 million At-The-Market equity program, with some viewing the dilution as a necessary step to fund R&D while others fear further stock price collapse. The community remains deeply divided, balancing excitement over the company's post-quantum cryptography pilots and hardware development against concerns regarding its lack of revenue and the volatile public feud between company leadership.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is rallying as investors await critical Phase 3 VELA 52-week clinical data, which many anticipate will confirm the company's leading position in the Hidradenitis Suppurativa market. The community is heavily focused on the potential for a major valuation rerating or acquisition, with discussions centering on whether the upcoming trial results will trigger an M&A event or validate the asset's 'best-in-class' therapeutic potential.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently the subject of intense community debate as investors weigh speculative rumors of a potential SpaceX merger against concerns over autonomous driving safety incidents and recent leadership moves. While bulls are looking for a turnaround driven by robotics and AI infrastructure expansion, bears are highlighting ongoing technical weakness and concerns that the company's valuation remains disconnected from near-term execution.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is under intense focus as community members weigh the impact of new Chinese export restrictions on critical rare earth elements against the company's long-term strategic role as a domestic supplier. Investors are actively debating the stock's technical price action and recent insider activity while gauging whether domestic policy tailwinds and defense-sector demand can offset current geopolitical headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

2 ETFs to Watch for Outsized Volume on US Treasury & Dividend

Unusual trading activity puts two ETFs in focus as volume surges well above normal levels despite a broad market selloff.

Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?

Is iShares Select Dividend ETF (DVY) a Strong ETF Right Now?

What Is Driving The Selloff In OneMain Stock?

Equity

Attorney General James alleged that OneMain exploits its vulnerable customers by loading their already high-cost loans with expensive and often useless additional products like insurance policies.


FMC Corp Stock Rises — What Did The CEO Say To Drive Rally?

FMC’s CEO announced the plans while presenting at the BofA Global Agriculture and Materials Conference. 


ETFs in Focus as U.S. Economy Rebounds in Q2 

U.S. GDP grew 3% in Q2 2025, beating forecasts and easing recession fears as investors eye VTV, XLU, DVY, DFUV and SPYD.

iShares Trust - iShares Select Dividend ETF

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

DVYiShares Select Dividend ETF

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest DVY News